Stryker ABG II, Rejuvenate Modular Hip Lawsuits Centralized in NJ

|

The Supreme Court of New Jersey has approved the consolidation of all product liability lawsuits over the recalled Stryker ABG II and Rejuvenate modular hip stem components, placing the state court litigation before one judge for coordinated handling during pretrial proceedings. 

In September 2012, a group of plaintiffs filed a request to consolidate all Stryker ABG II and Rejuvenate hip lawsuits pending in New Jersey state court as part of a Multi-County Litigation, or MCL.

In an order (PDF) issued on January 15, the Supreme Court of New Jersey ordered that all cases will be centralized before Judge Brian R. Martinotti in the Superior Court of New Jersey in Bergen County, and an initial status conference has been scheduled for February 20.

"*" indicates required fields

"*" indicates required fields

At the time the request was filed, there were at least 10 cases pending in New Jersey state court involving personal injuries associated with the Stryker ABG II or Rejuvenate modular hip stems, which were removed from the market in July 2012 amid reports that the component may be prone to fret and fail. However, it is expected that the number of lawsuits filed in the state will continue to increase in the coming months as hip replacement lawyers continue to review and file additional complaints.

Unlike traditional hip implants, which feature a single femoral component, the Stryker ABG II and Rejuvenate hip stems are modular, featuring two pieces that fit inside each other to allow the surgeon to customize the length based on the patient. However, Stryker recalled the ABG II and Rejuvenate components only a few years after the design was introduced, due to an increased risk of pain, swelling and failure of the artificial hip replacement that may occur as the metal parts rub against each other.

Consolidation of the Stryker ABG II and Rejuvenate litigation in New Jersey state court is designed to reduce duplicative discovery, avoid contradictory rulings from different judges and to serve the convenience of the court, the witnesses, the plaintiffs and the defendants.

The lawsuits involve many common allegations, suggesting problems with the Stryker ABG II and Rejuvenate hips could have been avoided if the manufacturer had properly researched the design and provided adequate warnings about the increased risk of early failure, which often results in the need for revision surgery to remove the implant.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Ocaliva, promoted as a treatment to prevent liver injury, has been recalled following reports of high rates of liver damage and patient deaths.
Women are sharing alarming reports of pain, infections, and reconstruction failures caused by internal bra mesh implants like GalaFLEX, as the FDA confirms these devices were never approved for breast surgery and lawsuits now allege manufacturers failed to warn about the risks.